- Home
- OCS vs BRSP Comparison
OCS vs BRSP Comparison
Compare OCS & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- BRSP
- Stock Information
- Founded
- OCS 2003
- BRSP 2017
- Country
- OCS Switzerland
- BRSP United States
- Employees
- OCS N/A
- BRSP N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- BRSP Real Estate Investment Trusts
- Sector
- OCS Health Care
- BRSP Real Estate
- Exchange
- OCS Nasdaq
- BRSP Nasdaq
- Market Cap
- OCS 689.8M
- BRSP 561.8M
- IPO Year
- OCS N/A
- BRSP 2018
- Fundamental
- Price
- OCS $18.27
- BRSP $4.50
- Analyst Decision
- OCS Strong Buy
- BRSP Buy
- Analyst Count
- OCS 4
- BRSP 4
- Target Price
- OCS $30.25
- BRSP $7.00
- AVG Volume (30 Days)
- OCS 48.2K
- BRSP 1.0M
- Earning Date
- OCS 05-07-2025
- BRSP 04-29-2025
- Dividend Yield
- OCS N/A
- BRSP 14.24%
- EPS Growth
- OCS N/A
- BRSP N/A
- EPS
- OCS N/A
- BRSP N/A
- Revenue
- OCS $757,024.00
- BRSP $358,805,000.00
- Revenue This Year
- OCS $57.00
- BRSP N/A
- Revenue Next Year
- OCS $1,820.89
- BRSP $25.80
- P/E Ratio
- OCS N/A
- BRSP N/A
- Revenue Growth
- OCS N/A
- BRSP N/A
- 52 Week Low
- OCS $10.79
- BRSP $4.16
- 52 Week High
- OCS $23.08
- BRSP $6.71
- Technical
- Relative Strength Index (RSI)
- OCS 52.53
- BRSP 28.49
- Support Level
- OCS $14.00
- BRSP $4.16
- Resistance Level
- OCS $16.39
- BRSP $4.54
- Average True Range (ATR)
- OCS 0.94
- BRSP 0.25
- MACD
- OCS 0.22
- BRSP -0.06
- Stochastic Oscillator
- OCS 71.40
- BRSP 23.13
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.